These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
174 related items for PubMed ID: 18284451
1. Phase I study of chemoradiation with nedaplatin and ifosfamide in patients with advanced squamous cell carcinoma of the uterine cervix. Kodama J, Takemoto M, Seki N, Nakamura K, Hongo A, Moriya S, Kanazawa S, Hiramatsu Y. Int J Gynecol Cancer; 2008; 18(6):1300-4. PubMed ID: 18284451 [Abstract] [Full Text] [Related]
3. Concurrent chemoradiotherapy with paclitaxel and nedaplatin followed by consolidation chemotherapy in locally advanced squamous cell carcinoma of the uterine cervix: preliminary results of a phase II study. Zhang MQ, Liu SP, Wang XE. Int J Radiat Oncol Biol Phys; 2010 Nov 01; 78(3):821-7. PubMed ID: 20207507 [Abstract] [Full Text] [Related]
4. Concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed by consolidation chemotherapy in locally advanced squamous cell carcinoma of the uterine cervix: results of a phase II study. Vrdoljak E, Prskalo T, Omrcen T, Situm K, Boraska T, Frleta Ilić N, Janković S, Hamm W. Int J Radiat Oncol Biol Phys; 2005 Mar 01; 61(3):824-9. PubMed ID: 15708262 [Abstract] [Full Text] [Related]
6. Phase I trial of concurrent chemoradiation with weekly nedaplatin in patients with squamous cell carcinoma of the uterine cervix. Yoshinaga K, Niikura H, Ogawa Y, Nemoto K, Nagase S, Takano T, Ito K, Yaegashi N. Gynecol Oncol; 2007 Jan 01; 104(1):36-40. PubMed ID: 16889822 [Abstract] [Full Text] [Related]
8. Salvage combined chemotherapy with paclitaxel, ifosfamide and nedaplatin for patients with advanced germ cell tumors. Nakamura T, Ueda T, Oishi M, Nakanishi H, Fujihara A, Naya Y, Hongo F, Kamoi K, Okihara K, Miki T. Int J Urol; 2015 Mar 01; 22(3):288-93. PubMed ID: 25393104 [Abstract] [Full Text] [Related]
9. [Comparison of two different chemotherapy regimens for concurrent chemoradiotherapy in stage Ib2 to IVa squamous cell carcinoma of the uterine cervix]. Li XF, Li YH, Gao YN, Li CL, Yue HZ, Xu G, Li DM, Su X. Zhonghua Fu Chan Ke Za Zhi; 2013 Oct 01; 48(10):763-7. PubMed ID: 24406134 [Abstract] [Full Text] [Related]
10. A phase II trial of less than 7 weeks of concomitant cisplatin-paclitaxel chemoradiation in locally advanced cervical cancer. Martínez-Monge R, Gaztañaga M, Aramendía JM, Cambeiro M, Arbea L, Espinós J, Aristu JJ, Jurado M. Int J Gynecol Cancer; 2010 Jan 01; 20(1):133-40. PubMed ID: 20130514 [Abstract] [Full Text] [Related]
16. [Combination chemotherapy with 254-S, ifosfamide and peplomycin for advanced or recurrent cervical cancer]. Hirabayashi K, Okada E, Nakazuma Y, Akamatsu Y, Sezaki H, Ohta M, Nakanishi Y. Nihon Sanka Fujinka Gakkai Zasshi; 1992 Mar 01; 44(3):341-8. PubMed ID: 1376759 [Abstract] [Full Text] [Related]
18. High complete response rate of concomitant chemoradiotherapy for locally advanced squamous cell carcinoma of the uterine cervix. Lin JC, Ho ES, Jan JS, Yang CH, Liu FS. Gynecol Oncol; 1996 Apr 01; 61(1):101-8. PubMed ID: 8626094 [Abstract] [Full Text] [Related]